Accelerated Radiation Therapy for Lung Cancer
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 45 (estimated)
- Sponsor
- Stanford University · Other
This trial is looking for adults with locally advanced lung cancer who are receiving radiation therapy and other treatments. Participants will undergo a specific type of radiation therapy aimed at their tumor.
You may be able to join if
- I have been diagnosed with lung cancer
- I am at least 18 years old
- I understand and can sign the consent form
- I am expected to live 12 weeks or longer
- I have an ECOG performance status of 0-2
You may not be able to join if
- I am under 18 years old
- I cannot receive radiation or other therapy as per my doctors
- My tumor invades major blood vessels or vital organs
- I have interstitial pulmonary fibrosis
- I have had previous radiation therapy to my chest area that overlaps with the new treatment
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe purpose of this study is to examine the use of hypofractionated accelerated radiation therapy (HART) to treat locally advanced lung cancer. Depending on the location and size of the tumor.
Loading trial locations…